Medical devices, healthcare technology and the business of care
510(k) clearance · K262460

Rezum System

Boston Scientific · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK262460

What did the FDA decide?

FDA's 510(k) database records K262460 for the Rezum System, submitted by Boston Scientific of Marlborough, Massachusetts. The record lists the device classification as Unit, Electrosurgical, Endoscopic (With Or Without Accessories), regulation number 876.4300, product code KNS, and review under the Gastroenterology/Urology panel. The application was received on 07/17/2026 and decided on 09/03/2026 as Substantially Equivalent (SESE), a 510(k) clearance rather than a PMA approval. The record describes the filing as Traditional, not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan.

The public record does not identify which components or modifications were assessed, nor does it state indications, performance data or review rationale. Those details would sit in the underlying 510(k) documents, which are not included here. The page shows two different last-updated dates, 09/14/2026 and 09/21/2026, across captures of the same record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262460
Regulatory pathway
510(k) premarket notification
Product code
KNS
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Unit, Electrosurgical, Endoscopic (With Or Without Accessories).

Product code
KNS
FDA device class
2

FDA decision timeline

  1. K262460 received

    Application receipt date recorded by FDA.

  2. K262460 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific

Headquarters
Not reported
FDA applicant address
Marlborough, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records